63 results
8-K
EX-1.1
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
and the Company shall deliver the other items required pursuant to Section 2.3 deliverable at the Closing. Upon satisfaction of the covenants … in the Registration Statement or the Prospectus or otherwise) shall have been complied with to the satisfaction of the Commission and the Underwriter
8-K
CGTX
Cognition Therapeutics Inc
13 Mar 24
Entry into a Material Definitive Agreement
4:07pm
, 2024, subject to the satisfaction of customary closing conditions.
The Shares will be issued pursuant to a Registration Statement on Form S-3 (File
424B5
CGTX
Cognition Therapeutics Inc
13 Mar 24
Prospectus supplement for primary offering
4:04pm
to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted
424B5
CGTX
Cognition Therapeutics Inc
11 Mar 24
Prospectus supplement for primary offering
4:06pm
of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any then outstanding
8-K
EX-10.1
2pmmsew6 8m1
20 Feb 24
Departure of Directors or Certain Officers
4:44pm
424B4
3i1vz38
8 Jan 24
Prospectus supplement with pricing info
4:11pm
8-K
EX-10.1
o3i2dqwsdn7jtuez21
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
EX-4.4
ec0zys389s9e05
23 Dec 22
Shelf registration
4:16pm
S-3
m1yu1e skhc1qgk
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
3jygpb05lncfsf
23 Dec 22
Shelf registration
4:16pm
8-K
EX-1.1
r28tlz9933f2df0g0wx
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-99.2
lag56futa
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
babug c2yot
14 Nov 22
Prospectus supplement with pricing info
6:02am